Advanced Hybridoma Technology & Monoclonal Antibody Production Service

Background Platform Production Packages Large-Scale Production Related Services Advantage FAQs Online Inquiry

At Creative Biolabs, we have been at the forefront of antibody innovation for over two decades. Our world-class team of biotechnology experts harnesses the power of advanced hybridoma technology to deliver high-quality, specific, and reliable monoclonal antibodies tailored to your research needs. This page details our comprehensive Hybridoma Technology & Antibody Production Services, designed to accelerate your journey from antigen to discovery.

Discuss Your Project Today

Harnessing the Gold Standard: The Power of Hybridoma Technology

Hybridoma technology remains the gold standard for generating robust monoclonal antibodies (mAbs). This well-established method provides a reliable platform for producing antibodies with high specificity, affinity, and batch-to-batch consistency. By immortalizing individual B cells, we create a perpetual source of your unique antibody, ensuring long-term availability for your research.

Key Advantages of Hybridoma-Developed Monoclonal Antibodies:

High Specificity & Affinity: Generate antibodies that recognize a single, specific epitope on your target antigen.
Homogeneity & Consistency: Produce a homogenous population of antibodies, ensuring reproducible results in your assays.
Long-Term, Stable Supply: Hybridoma cell lines provide a continuous and reliable source of your specific monoclonal antibody.
Versatility: Suitable for a wide range of applications, including ELISA, Western Blot, flow cytometry, immunohistochemistry, and functional assays.

Hybridoma. (Creative Biolabs Original). Fig.1 Hybridoma technology.

Advanced Hybridoma Development Platforms

We go beyond traditional methods by incorporating the latest technological advancements to enhance efficiency and success rates.

Electrofusion Technology: Our advanced electrofusion platform significantly increases fusion efficiency compared to traditional PEG-mediated fusion, resulting in a higher number of positive hybridoma clones.
Targeted B Cell Sorting & Screening: Utilizing state-of-the-art flow cytometry and B cell sorting technologies, we can isolate antigen-specific B cells prior to fusion. This targeted approach enriches for B cells producing high-affinity antibodies, streamlining the screening process.
High-Throughput Screening: Our automated, high-throughput screening platforms allow for the rapid identification of hybridomas secreting antibodies with the desired characteristics, including specificity, affinity, and functionality.

Custom Monoclonal Antibody Production Packages

We offer flexible and customizable service packages to meet the diverse needs of our clients.

Service Package	Description	Best For
Standard Mouse mAb	Our classic, comprehensive service for generating high-quality mouse monoclonal antibodies.	Standard research applications, assay development.
Rapid Mouse mAb	An accelerated timeline for projects requiring a faster turnaround.	Time-sensitive research, initial screening studies.
Rat Monoclonal Antibody	Ideal for generating antibodies against mouse antigens or when a rat host is preferred.	Mouse-on-mouse studies, specific immunology research.
Difficult Target & Low Immunogenicity	Specialized immunization strategies for challenging antigens like small molecules, peptides, and highly conserved proteins.	Projects with historically difficult targets.

Large-Scale Antibody Production

Once your lead hybridoma clone is identified, we offer scalable and reliable antibody production services.

In Vitro Cell Culture: We utilize optimized, serum-free, or low-serum culture conditions to produce high yields of pure monoclonal antibodies. This method ensures high batch-to-batch consistency and eliminates the risk of ascites-related contaminants.
Bioreactor Production: For gram-scale quantities, our state-of-the-art bioreactors provide a controlled environment for high-density cell culture, maximizing antibody yield and ensuring consistent quality.
Purification Services: We offer a range of purification options, including Protein A/G affinity chromatography, to achieve the desired purity level for your specific application.

Beyond Production: Downstream & Related Services

Custom Antibody & Hybridoma Services:

Creative Biolabs is your end-to-end partner for antibody development and application. Explore our related services to advance your research:

Antibody Sequencing & Hybridoma Sequencing: Ensure the long-term security and reproducibility of your hybridoma by sequencing the antibody variable regions.
Antibody Humanization: Reduce the immunogenicity of your murine antibodies for pre-clinical studies.
Antibody Affinity Measurement: Characterize the binding kinetics of your monoclonal antibody to its target.

Why Choose Creative Biolabs?

With over 20 years of dedicated experience in the biotechnology industry, Creative Biolabs stands as a pillar of expertise and reliability in monoclonal antibody development.

Unparalleled Expertise: Our team of Ph.D.-level scientists possesses deep knowledge and hands-on experience in immunology, cell biology, and antibody engineering.
Proven Track Record: We have successfully completed thousands of hybridoma development and antibody production projects for clients across academia, and the biotechnology and pharmaceutical industries.
Cutting-Edge Technology: We continuously invest in the latest technologies to provide our clients with the most advanced and efficient solutions.
Customized Project Design: We work closely with you to understand your specific research goals and design a project strategy tailored to your needs.
Transparent Communication: We provide regular project updates and are always available to discuss your project's progress.

Frequently Asked Questions (FAQs)

Q: What is the typical timeline for custom monoclonal antibody development?

A: Our standard mouse monoclonal antibody development service typically takes 3-4 months from antigen receipt to the delivery of purified antibody from selected clones. We also offer a rapid service with a timeline of approximately 2 months.

Q: What type of antigens can be used?

A: We can work with a wide variety of antigens, including recombinant proteins, purified native proteins, peptides, small molecules, and whole cells. Our experts can assist you in designing the optimal immunization strategy for your specific antigen.

Q: How do you ensure the specificity of the antibodies?

A: We employ a multi-step screening process, including ELISA and Western Blotting against the target antigen and any relevant counter-targets. For more specific requirements, we can incorporate additional screening assays such as flow cytometry or IHC.

Q: What is the deliverable for a hybridoma development project?

A: Standard deliverables include a specified number of positive hybridoma clones, purified monoclonal antibody from each clone, and a comprehensive final report detailing the project's methodology and results.

Q: Do you offer services for therapeutic antibody development?

A: The services described on this page are for research use only. However, we do offer specialized platforms and services for therapeutic antibody discovery and development under different service frameworks. Please contact us for more information.

Let's Start Your Discovery Journey

Ready to develop a high-quality monoclonal antibody for your research? Contact us today to discuss your project with one of our specialists. Our team is ready to provide you with a customized solution that meets your scientific and budgetary needs.

Contact Us Today for a Free Quote!

Reference

Mitra, Sanchita, and Pushpa Chaudhary Tomar. "Hybridoma technology; advancements, clinical significance, and future aspects." Journal of Genetic Engineering and Biotechnology 19 (2021): 1-12. https://doi.org/10.1186/s43141-021-00264-6

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.